Compound Detail
CHEMBL742
KETAMINE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL742 |
| Name | KETAMINE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | YQEZLKZALYSWHR-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
9
Targets
45
Activities
2
Assay Types
16
PK Parameters
20
Publications
16
Known Names
20
Indications
Molecular Properties
237.7
MW (Da)
2.90
ALogP
2
HBA
1
HBD
29.1
PSA (Ų)
0.86
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1970 |
| Availability | Prescription |
| Chirality | Racemic |
Indications
Alcoholism Anemia, Sickle Cell Bipolar Disorder Chronic Pain Delirium Depression, Postpartum Depressive Disorder Depressive Disorder, Major Epilepsy Fractures, Bone Headache Lung Diseases Mucositis Neoplasms Neuralgia Obesity, Morbid Pain Pharyngitis Postoperative Complications Renal Colic
ATC Classification
N01AX03
ketamine
Level 1: NERVOUS SYSTEM
Level 2: ANESTHETICS
Activity Summary
Ki 25 meas. best 6.75
IC50 20 meas. best 6.21
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Glutamate NMDA receptor; GRIN1/GRIN2A CHEMBL1907604 | Ki | 6.75 | 6.75 | 180.0 | 1 |
| Glutamate NMDA receptor CHEMBL1907608 | Ki | 6.75 | 6.75 | 180.0 | 13 |
| Glutamate [NMDA] receptor CHEMBL2094124 | Ki | 6.75 | 6.4 | 180.0 | 4 |
| Glutamate NMDA receptor; Grin1/Grin2b CHEMBL2096666 | Ki | 6.75 | 6.75 | 180.0 | 1 |
| Glutamate NMDA receptor; Grin1/Grin2a CHEMBL2096680 | Ki | 6.75 | 6.75 | 180.0 | 1 |
| Unchecked CHEMBL612545 | Ki | 6.75 | 6.634 | 180.0 | 5 |
| Glutamate NMDA receptor CHEMBL1907608 | IC50 | 6.21 | 5.7833 | 610.0 | 6 |
| Glutamate NMDA receptor; Grin1/Grin2a CHEMBL2096680 | IC50 | 6.0 | 6.0 | 1000.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 6.0 | 5.04 | 1010.0 | 2 |
| Glutamate NMDA receptor; GRIN1/GRIN2A CHEMBL1907604 | IC50 | 5.9 | 5.53 | 1258.9 | 3 |
| Voltage-dependent L-type calcium channel subunit alpha-1C CHEMBL1940 | IC50 | 5.75 | 5.75 | 1800.0 | 1 |
| Glutamate NMDA receptor; GRIN1/GRIN2B CHEMBL1907603 | IC50 | 5.5 | 5.4 | 3200.0 | 2 |
| Acetylcholine receptor subunit alpha CHEMBL3097 | IC50 | 5.3 | 5.13 | 4950.0 | 2 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 136.0 | mL.min-1.g-1 | Homo sapiens |
| CL | 19.0 | mL.min-1.kg-1 | Homo sapiens |
| Cmax | 7600.0 | nM | Homo sapiens |
| F | 20.0 | % | Homo sapiens |
| F | 93.0 | % | Homo sapiens |
| F | 17.0 | % | Homo sapiens |
| F | 100.0 | % | Homo sapiens |
| F | 8.0 | % | Homo sapiens |
| F | 11.0 | % | Homo sapiens |
| F | 24.0 | % | Homo sapiens |
| Fu | 0.47 | - | Homo sapiens |
| MRT | 2.5 | hr | Homo sapiens |
| T1/2 | 2.8 | hr | Homo sapiens |
| T1/2 | 2.0 | hr | Homo sapiens |
| T1/2 | 8.0 | hr | Rattus norvegicus |
| T1/2 | 0.1167 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine